Gameto
PrivateLast Round
Series C
Aug 12, 2025
Est. Valuation
$243M
Total Funding Raised
$127M
Company Overview
Gameto operates in Healthcare & Life Sciences and is based in Austin, Texas. Its latest recorded funding round was a Series C round in August 2025.
Gameto is a biotechnology company that develops cell engineering platforms to create novel treatments for women's reproductive health, including infertility and ovarian aging.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Devices, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Gameto Comparables
Compare Gameto with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Lavima Fertility | 88% | |
| Vitra Labs | 81% | |
| Conception | 81% |
For institutional investors. Book with your work email.
Gameto Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Aug 12, 2025 | ||||
| Grant | Oct 23, 2024 | ||||
| Series B | May 29, 2024 | ||||
| Series A Extension | Sep 14, 2022 | ||||
| Series A | Jan 10, 2022 | ||||
Seed | Mar 1, 2020 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Gameto Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| RA Capital Management | Series C, Series B |
| Future Ventures | Series B, Series C, Series A Extension, Series A |
| Khosla Ventures | Series C |
| Pontiva Healthcare Partners | Series C |
| Gaingels | Series A Extension, Series A |
| Portfolia | Series C |
| Pags Group | Series C |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 25, 2026
Monthly visitors increased 35% MoM, reaching 6.4K.
- Apr 16, 2026
Monthly visitors increased 43% MoM, reaching 7.8K.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- is_developingOct 27, 2026
Gameto, Inc. is working on Deovo, an in vitro model of the female reproductive system intended to aid the discovery and development of drugs for women.
For institutional investors. Book with your work email.
Gameto Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Gameto's valuation, stock price, and market status.
Is Gameto a public or private company?
Gameto is a private company.
What is the current stock price of Gameto?
Gameto is a private company, so its shares have no public market price. Caplight tracks Gameto's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Gameto worth (valuation)?
Gameto's valuation is estimated at $243.0M based on funding round data.
Can I buy Gameto stock?
Gameto shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Gameto's last funding round?
Gameto's most recent funding round was Series C on August 12, 2025.
Who are the main investors in Gameto?
Key investors in Gameto include RA Capital Management, Future Ventures, Two Sigma Ventures, ARPA-H, Overwater Ventures.
Will Gameto IPO soon?
No public IPO plans have been announced for Gameto.
How can I track Gameto secondary market activity?
Caplight tracks bids, offers, and trades in Gameto's shares on secondary markets.